Publications by authors named "A Kubesch"
Inflammatory bowel disease (IBD) remains an incurable illness. Patients with IBD show gender-specific differences in various aspects of the disease. There is still uncertainty about the causality of the differences.
View Article and Find Full Text PDFArticle Synopsis
- A study assessed a new ultrasound-based algorithm for determining when to remove pancreatic stents placed to prevent post-ERCP pancreatitis, aiming to minimize unnecessary X-ray imaging.
- Out of 88 patients, the ultrasound approach successfully reduced the need for X-rays by 74%, accurately visualizing stents in 81% of cases but with limited specificity.
- The authors recommend implementing the ultrasound algorithm with training for experienced personnel due to challenges with visualizing shorter stents.
Background: Vedolizumab (VDZ) for subcutaneous (SC) injection was approved for use in Europe in 2020 and the US in 2023. Promising efficacy and tolerability have been proven in pivotal trials. However, real-world data on the SC use of VDZ, especially in patients with active disease, are still lacking.
View Article and Find Full Text PDFBackground And Aim: The main disadvantage of plastic stents is the high rate of stent occlusion. The usual replacement interval of biliary plastic stents is 3 months. This study aimed to investigate if a shorter interval of 6-8 weeks impacts the median premature exchange rate (mPER) in benign and malignant biliary strictures.
View Article and Find Full Text PDFIntroduction: Aortoesophageal fistula (AEF) is a life-threatening complication associated with endovascular aortic repair (EVAR) and occurs mostly in patients who undergo thoracic EVAR (TEVAR). To date, surgical treatment of AEF has been considered the most promising therapeutic approach. New endoscopic techniques could contribute to the therapy of AEF.
View Article and Find Full Text PDF